 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Denali Therapeutics Inc. (DNLI)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-30 Sale | 2020-04-01 6:19 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 1,428 | $19.48 | $27,817 | 1,006,488 (Direct) | View |
| 2020-03-30 Sale | 2020-04-01 6:19 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 1,427 | $19.49 | $27,812 | 28,662 (Indirect Direct) | View |
| 2020-03-30 Sale | 2020-04-01 6:18 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 1,428 | $19.48 | $27,817 | 2,822 (Direct Indirect) | View |
| 2020-03-30 Sale | 2020-04-01 6:17 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 4,807 | $19.48 | $93,640 | 22,013 (Indirect Direct) | View |
| 2020-02-26 Sale | 2020-02-28 4:25 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 3,894,764 | $20.25 | $78,868,971 | 15,567,736 (Indirect) | View |
| 2019-12-19 Sale | 2019-12-23 7:35 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 6,890 | $20.01 | $137,835 | 0 (Direct Indirect) | View |
| 2019-12-03 Sale | 2019-12-05 5:16 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 7,500 | $18 | $135,017 | 25,839 (Indirect Direct) | View |
| 2019-12-03 Sale | 2019-12-05 4:29 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 21,268 | $18 | $382,874 | 2,429,304 (Direct Indirect) | View |
| 2019-11-22 Sale | 2019-11-26 6:17 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 43,485 | $18.02 | $783,574 | 2,450,572 (Direct Indirect) | View |
| 2019-11-22 Sale | 2019-11-26 5:08 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 15,000 | $18.02 | $270,287 | 584,378 (Direct Indirect) | View |
| 2019-09-09 Sale | 2019-09-11 4:38 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 7,500 | $18.16 | $136,200 | 610,089 (Direct Indirect) | View |
| 2019-09-03 Sale | 2019-09-05 6:51 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 8,581 | $18.05 | $154,894 | 2,494,057 (Direct Indirect) | View |
| 2019-08-07 Sale | 2019-08-09 6:35 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 7,500 | $18.81 | $141,075 | 617,589 (Direct Indirect) | View |
| 2019-07-08 Sale | 2019-07-10 5:08 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 7,500 | $20.28 | $152,135 | 625,089 (Direct Indirect) | View |
| 2019-07-08 Sale | 2019-07-10 5:07 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 17,500 | $20.29 | $355,011 | 79,934 (Direct Indirect) | View |
| 2019-05-14 Sale | 2019-07-03 4:47 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 18,333 | $20.76 | $380,593 | 2,502,638 (Direct Indirect) | View |
| 2019-06-10 Sale | 2019-06-12 6:14 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 7,500 | $18.77 | $140,775 | 632,589 (Direct Indirect) | View |
| 2019-06-10 Sale | 2019-06-12 6:13 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 17,500 | $18.78 | $328,653 | 90,923 (Direct Indirect) | View |
| 2019-06-03 Sale | 2019-06-05 5:15 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 18,333 | $19.07 | $349,610 | 2,560,971 (Direct Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-02-07 Exercise | 2020-04-01 6:16 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 4,250 | $0 | 12,750 (Direct) | View |
| 2020-02-07 Exercise | 2020-04-01 6:16 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 4,250 | $0 | 12,750 (Direct) | View |
| 2020-02-07 Exercise | 2020-04-01 6:15 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 4,250 | $0 | 12,750 (Direct) | View |
| 2020-02-07 Exercise | 2020-04-01 6:15 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 4,250 | $0 | 12,750 (Direct) | View |
| 2019-02-07 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,250 | $0 | 12,750 (Direct) | View |
| 2019-02-07 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,250 | $0 | 12,750 (Direct) | View |
| 2020-02-08 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 5,515 | $0 | 26,400 (Direct) | View |
| 2020-02-08 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 8,800 | $0 | 26,400 (Direct) | View |
| 2020-02-08 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 5,515 | $0 | 26,400 (Direct) | View |
| 2020-02-08 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 8,800 | $0 | 26,400 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:03 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 29,143 | $0 | 136,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:03 pm | N/A 2030-02-09 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 136,000 | $24.81 | 136,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:03 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 29,143 | $0 | 136,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:03 pm | N/A 2030-02-09 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 136,000 | $24.81 | 136,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:02 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 78,787 | $0 | 367,675 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:02 pm | N/A 2030-02-09 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 367,675 | $24.81 | 367,675 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:01 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 29,874 | $0 | 142,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:01 pm | N/A 2030-02-09 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 142,000 | $24.81 | 142,000 (Direct) | View |
| 2019-12-03 Exercise | 2019-12-05 5:16 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 711 | $5.28 | 25,839 (Direct) | View |
| 2019-12-03 Exercise | 2019-12-05 5:16 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 3,121 | $5.28 | 25,839 (Direct) | View |
| 2019-12-03 Exercise | 2019-12-05 5:16 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 711 | $5.28 | 25,839 (Direct) | View |
| 2019-12-03 Exercise | 2019-12-05 5:16 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 3,121 | $5.28 | 25,839 (Direct) | View |
| 2019-10-23 Exercise | 2019-10-25 5:05 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 5,129 | $5.28 | 112,769 (Direct) | View |
| 2019-10-23 Exercise | 2019-10-25 5:05 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 5,129 | $5.28 | 112,769 (Direct) | View |
| 2019-08-20 Exercise | 2019-08-22 7:49 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 5,643 | $0 | 5,643 (Direct) | View |
| 2019-08-20 Tax Withholding | 2019-08-22 7:49 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 1,975 | $18.6 | 5,643 (Direct) | View |
| 2019-08-20 Exercise | 2019-08-22 7:49 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 5,643 | $0 | 5,643 (Direct) | View |
| 2019-08-20 Exercise | 2019-08-22 7:49 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,643 | $0 | 5,643 (Direct) | View |
| 2019-08-20 Tax Withholding | 2019-08-22 7:49 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,834 | $18.59 | 5,643 (Direct) | View |
| 2019-08-20 Exercise | 2019-08-22 7:49 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,643 | $0 | 5,643 (Direct) | View |
| 2019-08-20 Exercise | 2019-08-22 7:48 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 5,643 | $0 | 5,643 (Direct) | View |
| 2019-08-20 Tax Withholding | 2019-08-22 7:48 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 1,977 | $18.59 | 5,643 (Direct) | View |
| 2019-08-20 Exercise | 2019-08-22 7:48 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 5,643 | $0 | 5,643 (Direct) | View |
| 2019-08-08 Other | 2019-08-12 8:49 pm | N/A N/A | Denali Therapeutics Inc. | DNI | NELSEN ROBERT Director 10% Owner | 400,000 | $0 | 2,030 (Indirect) | View |
| 2019-08-08 Other | 2019-08-12 8:49 pm | N/A N/A | Denali Therapeutics Inc. | DNI | NELSEN ROBERT Director 10% Owner | 2,030 | $0 | 2,030 (Direct) | View |
| 2019-08-08 Other | 2019-08-12 8:47 pm | N/A N/A | Denali Therapeutics Inc. | DNI | ARCH Venture Fund VIII L.P. ARCH Venture Partners VIII L.P. ARCH Venture Partners VIII LLC BYBEE CLINTON CRANDELL KEITH 10% Owner | 400,000 | $0 | 10,668,749 (Direct) | View |
| 2019-07-08 Exercise | 2019-07-10 5:07 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,604 | $5.28 | 79,934 (Direct) | View |
| 2019-07-08 Exercise | 2019-07-10 5:07 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 3,907 | $5.28 | 79,934 (Direct) | View |
| 2019-07-08 Exercise | 2019-07-10 5:07 pm | N/A 2026-07-01 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,604 | $5.28 | 79,934 (Direct) | View |
| 2019-07-08 Exercise | 2019-07-10 5:07 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 3,907 | $5.28 | 79,934 (Direct) | View |
| 2019-05-14 Gift | 2019-07-03 4:47 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 40,000 | $0 | 2,502,638 (Indirect) | View |
| 2019-06-10 Exercise | 2019-06-12 6:13 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 711 | $5.28 | 90,923 (Direct) | View |
| 2019-06-10 Exercise | 2019-06-12 6:13 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 3,906 | $5.28 | 90,923 (Direct) | View |
| 2019-06-10 Exercise | 2019-06-12 6:13 pm | N/A 2026-07-01 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 711 | $5.28 | 90,923 (Direct) | View |
| 2019-06-10 Exercise | 2019-06-12 6:13 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 3,906 | $5.28 | 90,923 (Direct) | View |
| 2019-05-30 Option Award | 2019-06-03 7:30 pm | N/A 2029-05-29 | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 27,245 | $19.5 | 27,245 (Direct) | View |
| 2019-05-30 Option Award | 2019-06-03 5:00 pm | N/A 2029-05-29 | Denali Therapeutics Inc. | DNLI | NELSEN ROBERT Director 10% Owner | 27,245 | $19.5 | 27,245 (Direct) | View |
| 2019-05-30 Option Award | 2019-05-31 6:43 pm | N/A 2029-05-29 | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 27,245 | $19.5 | 27,245 (Direct) | View |
| 2019-05-30 Option Award | 2019-05-31 6:39 pm | N/A 2029-05-29 | Denali Therapeutics Inc. | DNLI | Klein Peter S Director | 27,245 | $19.5 | 27,245 (Direct) | View |
| 2019-05-30 Option Award | 2019-05-31 6:38 pm | N/A 2029-05-29 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 27,245 | $19.5 | 27,245 (Direct) | View |
| 2019-05-30 Option Award | 2019-05-31 6:36 pm | N/A 2029-05-29 | Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director | 27,245 | $19.5 | 27,245 (Direct) | View |
| 2019-05-30 Option Award | 2019-05-31 6:34 pm | N/A 2029-05-29 | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 27,245 | $19.5 | 27,245 (Direct) | View |